Results 211 to 220 of about 112,698 (266)

Chronic myeloid leukemia in blast phase masquerading as T-lymphoblastic lymphoma with t(22;22) karyotype: a case report. [PDF]

Front Oncol
Liu Y, Hao Z, Bai J, Zhou W, Zhang H, Guan Z, Zhang L, Li L.   +7 more
europepmc   +1 more source

Impact of Tyrosine Kinase Inhibitors on Estimated Glomerular Filtration Rate in Chronic Myeloid Leukemia Patients.

Oncology
Alshurafa A, Benkhadra M, Qasem NM, Babiker AM, Al-Asa'd Y, Haik MY, Yassin MA.   +6 more
europepmc   +1 more source

Digital Medicine and Artificial Intelligence in Chronic Myeloid Leukemia: Current Applications, Challenges, and Future Directions. [PDF]

Cureus
Asadov C, Shirinova A, Alimirzoyeva Z, Hasanova A.   +3 more
europepmc   +1 more source

Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. [PDF]

Cureus
Saburi M, Maehara K, Nishikawa T, Hiroyuki T, Sakata M, Kohno K, Ogata Y, Haruyama T, Ohtsuka E.   +8 more
europepmc   +1 more source

Impact of Beta-Thalassemia Trait on Clinical Outcomes and Treatment Response in Chronic Myeloid Leukemia. [PDF]

Cureus
Shirinova A, Asadov C, Hasanova A, Alimirzoyeva Z.   +3 more
europepmc   +1 more source

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Blood
Cortes JE, Hughes TP, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Etienne G, Kim I, Andorsky DJ, Bombaci F, Issa GC, Takahashi N, Kapoor S, Jinwal R, Malek K, McCulloch T, Yau L, Larson RA, Hochhaus A.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chronic Myeloid Leukemia

New England Journal of Medicine, 1999
Over the past twenty years, clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia. Basic science has defined the molecular pathogenesis of chronic myeloid leukemia (CML) as unregulated signal transduction by the Bcr-Abl tyrosine kinase.
Charles L Sawyers, Sawyers Charles L
exaly   +3 more sources

The Biology of Chronic Myeloid Leukemia

New England Journal of Medicine, 1999
Chronic myeloid leukemia (CML) is a clonal myeloproliferative expansion of transformed, primitive hematopoietic progenitor cells. It involves myeloid, monocytic, erythroid, megakaryocytic, B-lymphoid, and occasionally T-lymphoid lineages.1 CML was the first human disease in which a specific abnormality of the karyotype — the Philadelphia (Ph ...
Moshe Talpaz, Zeev Estrov, Susan O'Brien   +2 more
exaly   +3 more sources

Asciminib in chronic myeloid leukemia

Drugs of Today, 2022
Despite the fact that, in the last years, life expectancy of chronic myeloid leukemia (CML) patients has reached that of the normal population, a significant proportion of CML patients is likely to fail treatment with first- or second-generation tyrosine kinase inhibitors (TKIs).
Assanto, Giovanni Manfredi, Scalzulli, Emilia, Breccia, Massimo   +2 more
openaire   +3 more sources